Published in Helicobacter on August 01, 2005
High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. Saudi J Gastroenterol (2011) 1.05
Trends in the eradication rates of Helicobacter pylori infection for eleven years. World J Gastroenterol (2012) 0.88
Clarithromycin vs. Gemifloxacin in Quadruple Therapy Regimens for Empiric Primary Treatment of Helicobacter pylori Infection: A Randomized Clinical Trial. Middle East J Dig Dis (2015) 0.79
Prevalence of Helicobacter pylori in symptomatic patients and detection of clarithromycin resistance using melting curve analysis. Curr Ther Res Clin Exp (2007) 0.77
The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome. Rheumatol Int (2008) 0.75
Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH. J Pathol Clin Res (2016) 0.75
Entecavir therapy for lamivudine-refractory chronic hepatitis B: improved virologic, biochemical, and serology outcomes through 96 weeks. Hepatology (2008) 2.70
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents (2008) 2.02
Diagnostic and therapeutic ERCP in hepatic hydatid disease. Gastrointest Endosc (2003) 1.77
Cyclosporine level at the second hour in pediatric hematopoietic stem cell transplant patients. Exp Clin Transplant (2011) 1.44
Multicentre evaluation of central nervous system infections due to Flavi and Phleboviruses in Turkey. J Infect (2012) 1.43
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis. Am J Gastroenterol (2008) 1.17
Ameboma mimicking carcinoma of the cecum: case report. Gastrointest Endosc (2004) 1.10
Screening of tissue transglutaminase antibody in healthy blood donors for celiac disease screening in the Turkish population. Dig Dis Sci (2004) 1.09
Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol (2008) 1.09
A cluster of nosocomial Klebsiella oxytoca bloodstream infections in a university hospital. Infect Control Hosp Epidemiol (2004) 1.02
Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol (2007) 1.02
Epidemiologic trends in HBV infections at a reference centre in Turkey: an 11-year retrospective analysis. Ann Hepatol (2012) 0.99
Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis (2006) 0.97
Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine. Am J Gastroenterol (2006) 0.88
Neisseria meningitidis W135, Turkey. Emerg Infect Dis (2004) 0.88
In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital. Med Mycol (2005) 0.88
Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp. Antimicrob Agents Chemother (2003) 0.88
Evaluation of the Helicobacter pylori stool antigen test (HpSA) for the detection of Helicobacter pylori infection and comparison with other methods. Hepatogastroenterology (2003) 0.87
A hydatid cyst presenting as an axillary mass. Am J Med (2004) 0.86
Celiac disease in the Turkish population. Dig Dis Sci (2005) 0.86
The search for a common thrombophilic state during the active state of inflammatory bowel disease. J Clin Gastroenterol (2006) 0.86
Investigation of HSV-1, HSV-2, CMV, HHV-6 and HHV-8 DNA by real-time PCR in surgical resection materials of epilepsy patients with mesial temporal lobe sclerosis. J Neurol Sci (2007) 0.85
False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med (2005) 0.84
Frequency of HFE mutations among Turkish blood donors according to transferrin saturation: genotype screening for hereditary hemochromatosis among voluntary blood donors in Turkey. J Clin Gastroenterol (2004) 0.84
Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients. Pediatr Nephrol (2002) 0.83
Mutations of the HFE gene among Turkish hereditary hemochromatosis patients. Ann Hematol (2005) 0.83
Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). Ann Hepatol (2006) 0.83
Hepatocellular carcinoma and cholangiocarcinoma are associated with high serum levels of hepatocyte growth factor. Indian J Gastroenterol (2006) 0.82
The effect of premedication on preoperative anxiety. Middle East J Anaesthesiol (2005) 0.82
Ursodeoxycholic acid for terbinafine-induced toxic hepatitis. Ann Pharmacother (2004) 0.81
Clinical outcomes and therapeutic options of bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Int J Antimicrob Agents (2005) 0.81
Biochemical markers of bone turnover in diagnosis of myeloma bone disease. Am J Hematol (2007) 0.80
Late autoimmune hepatitis after hepatitis C therapy. Eur J Gastroenterol Hepatol (2013) 0.80
Coincidence or causality: celiac and Crohn diseases in a case of Turner syndrome. Am J Med Sci (2005) 0.79
Potassium abnormalities in current clinical practice: frequency, causes, severity and management. Med Princ Pract (2015) 0.79
Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population. J Clin Lab Anal (2011) 0.79
Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence. Hepatogastroenterology (2011) 0.78
Alpha-1 antitrypsin deficiency in patients with chronic hepatitis. Turk J Gastroenterol (2012) 0.78
The genotype frequencies of IL28B polymorphisms (rs12979860, rs8099917) among Turkish patients with hepatitis C. Eur J Gastroenterol Hepatol (2012) 0.78
Container type and bactericidal activity of human milk during refrigerated storage. J Hum Lact (2013) 0.78
Evidence for higher red blood cell mass in persons with unconjugated hyperbilirubinemia and Gilbert's syndrome. Am J Med Sci (2008) 0.78
Evaluation of multiplex real time polymerase chain reaction and procalcitonin in the diagnosis of sepsis. Clin Lab (2014) 0.78
Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother (2002) 0.78
Antimicrobial Activity of Copper Alloys Against Invasive Multidrug-Resistant Nosocomial Pathogens. Curr Microbiol (2015) 0.77
The preventive effect of low molecular weight heparin on CCL₄-induced necrosis and apoptosis in rat liver. Ann Hepatol (2010) 0.77
HFE mutations analysis of Turkish patients with nonalcoholic steatohepatitis. Dig Dis Sci (2006) 0.77
The value of increased neopterin levels in reducing transfusion-transmitted virus infections: detection of a donation from a HBsAg positive chronic carrier by screening of neopterin in Turkish blood donors. Scand J Infect Dis (2005) 0.77
Mapping of microsatellite instability in endoscopic normal colon. Genet Test Mol Biomarkers (2012) 0.76
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey. Scand J Infect Dis (2006) 0.76
Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients. Am J Gastroenterol (2009) 0.76
Diagnostic difficulties, therapeutic strategies, and performance of scoring systems in patients with autoimmune hepatitis and concurrent hepatitis B/C. Scand J Gastroenterol (2013) 0.75
Serum hepatocyte growth factor in autoimmune and hepatitis B-associated liver diseases. Indian J Gastroenterol (2007) 0.75
Neonatal cholestasis in gram-negative septicaemia. J Pediatr Gastroenterol Nutr (2012) 0.75
[Investigation of baseline antiviral resistance in treatment-naive chronic hepatitis B cases]. Mikrobiyol Bul (2013) 0.75
A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection. Med Oncol (2009) 0.75
Enricher reactor--permeable reactive biobarrier approach for removing a mixture of contaminants with substrate interactions. Bioresour Technol (2013) 0.75
Gastric cancer prevention from the point of Helicobacter. Turk J Gastroenterol (2014) 0.75
Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study. Arch Gynecol Obstet (2012) 0.75
Effects of freezing on the bactericidal activity of human milk. J Pediatr Gastroenterol Nutr (2012) 0.75
Independent Study Module for Lactation Consultants. J Hum Lact (2013) 0.75
Brucellosis in all patients with febrile neutropenia. Leuk Lymphoma (2006) 0.75
What is the future of research for hereditary hemochromatosis in Turkey. Turk J Gastroenterol (2013) 0.75
[Detection of resistance mutations in chronic hepatitis B patients receiving antiviral therapy for over one year]. Mikrobiyol Bul (2013) 0.75
Lamivudine treatment failure risks in chronic hepatitis B patients with low viral load. Digestion (2013) 0.75
What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection? J Hepatol (2008) 0.75